Research Article
I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
Cite this as:
BMJ
1975;1:12.2
- G R Catto,
- M MacLeod,
- B Pelc,
- E Kodicek
Abstract
Three patients with chronic renal failure on maintenance haemodialysis have been treated with 1 alpha-hydroxycholecalciferol (1 alpha-OHCC), a synthetic vitamin D analogue. A daily dose of 2 mug by mouth produced a significant increase in both calcium absorption from the gastrointestinal tract and calcium content of bone. Treatment with 1 alpha-OHCC appears to be effective in cases of metabolic bone disease associated with chronic renal failure.
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The example given is not, statistically and ethically, without faults
Published 28 May 2012
Re: The drug industry is a barrier to diabetes care in poor countries
Published 28 May 2012
Re: Comparisons of established risk prediction models for cardiovascular disease: systematic review
Published 28 May 2012
Re: Anonymised data of all NHS treatments must be put in public domain by 2015, strategy says
Published 28 May 2012
Re: Perfectionism in doctors
Published 28 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27